Phase II study of gefitinib adaptive dose escalation to skin toxicity in recurrent or metastatic squamous cell carcinoma of the head and neck

Cesar A. Perez, Hunho Song, Luis E. Raez, Mark Agulnik, Tatyana A. Grushko, Allison Dekker, Kerstin Stenson, Elizabeth A. Blair, Olufunmilayo I. Olopade, Tanguy Y. Seiwert, Everett E. Vokes, Ezra E.W. Cohen

Research output: Contribution to journal › Article › peer-review

33 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II study of gefitinib adaptive dose escalation to skin toxicity in recurrent or metastatic squamous cell carcinoma of the head and neck'. Together they form a unique fingerprint.

Medicine & Life Sciences